Therapeutic dissection after successful coronary balloon angioplasty: no influence on restenosis or on clinical outcome in 693 patients. The MERCATOR Study Group (Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis)

Thoraxcenter, Rotterdam, The Netherlands.

OBJECTIVES: The objective of this study was to examine the relation between an angiographically visible coronary dissection immediately after successful coronary balloon angioplasty and a subsequent restenosis and long-term clinical outcome. BACKGROUND. The study population comprised all 693 patients who participated in the MERCATOR trial (randomized, double-blind, placebo-controlled restenosis prevention trial of cilazapril, 5 mg two times a day). METHODS. Cineangiographic films were processed and analyzed at a central angiographic core laboratory, without knowledge of clinical data, with use of an automated interpolated edge detection technique. Dissection was judged according to the National Heart, Lung, and Blood Institute classification. Angiographic follow-up was obtained in 94% of patients with 778 lesions. Two approaches were used to assess the restenosis phenomenon: 1) categoric, using the traditional cutoff criterion of greater than 50% diameter stenosis at follow-up, and 2) continuous, defined as absolute change in minimal lumen diameter (mm) between the postcoronary angioplasty and follow-up, adjusted for the vessel size (relative loss). Clinical outcome was ranked according to the most serious adverse clinical event per patient during the 6-month follow-up period, ranging from death, nonfatal myocardial infarction, coronary revascularization and recurrent angina requiring medical therapy to none of these. RESULTS. Dissection was present in 247 (32%) of the 778 dilated lesions. The restenosis rate was 29% in lesions with and 30% in lesions without dissection (relative risk 0.97; 95% confidence interval 0.77 to 1.23). The relative loss in both groups was 0.10 (mean difference 0; 95% confidence interval -0.03 to 0.03). Clinical outcome ranged from death in 4 patients (0.9%) without dissection and 1 patient (0.4%) with dissection; nonfatal myocardial infarction in 4 (0.9%) without and 8 (3.2%) with dissection; coronary revascularization in 73 (16.6%) without and 32 (12.7%) with dissection; recurrent angina requiring medical therapy in 88 (20%) without and 47 (18.7%) with dissection to no serious adverse event in 272 (61.7%) without and 114 (65.1%) with dissection. CONCLUSIONS. These data indicate that a successfully dilated coronary lesion with an angiographically visible dissection is no more likely to develop restenosis, and is not associated with a worse clinical outcome, at 6-month follow-up than is a dilated lesion without visible dissection on the post-balloon angioplasty angiogram.

This article has been cited by other articles:

				G. G.L. Biondi-Zoccai, P. Agostoni, G. M. Sangiorgi, F. Airoldi, J. Cosgrave, A. Chieffo, R. Barbagallo, C. Tamburino, G. Vittori, E. Falchetti, et al. Incidence, predictors, and outcomes of coronary dissections left untreated after drug-eluting stent implantation Eur. Heart J., March 1, 2006; 27(5): 540 - 546. [Abstract] [Full Text] [PDF]

				E. Okmen, N. Cam, A. Sanli, F. Yapici, H. Uyarel, M. Vural, and R. Ozturk Effects of Direct Stent Implantation and Conventional Stent Implantation on Minor Myocardial Injury Angiology, September 1, 2004; 55(5): 485 - 491. [Abstract] [PDF]

				M Albertal, G Van Langenhove, E Regar, I P Kay, D Foley, G Sianos, K Kozuma, T Beijsterveldt, S G Carlier, J A Belardi, et al. Uncomplicated moderate coronary artery dissections after balloon angioplasty: good outcome without stenting Heart, August 1, 2001; 86(2): 193 - 198. [Abstract] [Full Text] [PDF]

				Tong Chuang Feng, Wang Yui Ying, Ren Jang Hua, Y. Y Ji, and M. de Gasparo Effect of valsartan and captopril in rabbit carotid injury. Possible involvement of bradykinin in the antiproliferative action of the renin-angiotensin blockade Journal of Renin-Angiotensin-Aldosterone System, March 1, 2001; 2(1): 19 - 24. [Abstract] [PDF]

				M A Costa, K Kozuma, A L Gaster, W J van der Giessen, M Sabaté, D P Foley, I P Kay, J M R Ligthart, P Thayssen, M J van den Brand, et al. Three dimensional intravascular ultrasonic assessment of the local mechanism of restenosis after balloon angioplasty Heart, January 1, 2001; 85(1): 73 - 79. [Abstract] [Full Text]

				I P Kay, M Sabate, G Van Langenhove, M A Costa, A J Wardeh, A L Gijzel, N V Deshpande, S G Carlier, V L M A Coen, P C Levendag, et al. Outcome from balloon induced coronary artery dissection after intracoronary beta radiation Heart, March 1, 2000; 83(3): 332 - 337. [Abstract] [Full Text]

				S. Schroeder, A. Baumbach, H. Mahrholdt, K.K. Haase, M. Oberhoff, C. Herdeg, A. Athanasiadis, and K.R. Karsch The impact of untreated coronary dissections on acute and long-term outcome after intravascular ultrasound guided PTCA Eur. Heart J., January 2, 2000; 21(2): 137 - 145. [Abstract] [PDF]

				A. Cappelletti, A. Margonato, G. Rosano, A. Mailhac, F. Veglia, A. Colombo, and S. L. Chierchia Short- and long-term evolution of unstented nonocclusive coronary dissection after coronary angioplasty J. Am. Coll. Cardiol., November 1, 1999; 34(5): 1484 - 1488. [Abstract] [Full Text] [PDF]

				P. W. Serruys, C. di Mario, J. Piek, E. Schroeder, C. Vrints, P. Probst, B. de Bruyne, C. Hanet, E. Fleck, M. Haude, et al. Prognostic Value of Intracoronary Flow Velocity and Diameter Stenosis in Assessing the Short- and Long-term Outcomes of Coronary Balloon Angioplasty : The DEBATE Study (Doppler Endpoints Balloon Angioplasty Trial Europe) Circulation, November 18, 1997; 96(10): 3369 - 3377. [Abstract] [Full Text]

				Y. Ozaki, A. G. Violaris, T. Kobayashi, D. Keane, E. Camenzind, C. Di Mario, P. de Feyter, J. R. T. C. Roelandt, and P. W. Serruys Comparison of Coronary Luminal Quantification Obtained From Intracoronary Ultrasound and Both Geometric and Videodensitometric Quantitative Angiography Before and After Balloon Angioplasty and Directional Atherectomy Circulation, July 15, 1997; 96(2): 491 - 499. [Abstract] [Full Text]

				Y. Ozaki, D. Keane, P. Ruygrok, W. J. van der Giessen, P. de Feyter, and P. W. Serruys Six-Month Clinical and Angiographic Outcome of the New, Less Shortening Wallstent in Native Coronary Arteries Circulation, June 15, 1996; 93(12): 2114 - 2120. [Abstract] [Full Text]

				Y. Ozaki, D. Keane, and P. W. Serruys Progression and Regression of Coronary Stenosis in the Long-term Follow-up of Vasospastic Angina Circulation, November 1, 1995; 92(9): 2446 - 2456. [Abstract] [Full Text]

				C. Bauters, J.-M. Lablanche, E. P. McFadden, M. Hamon, and M. E. Bertrand Relation of Coronary Angioscopic Findings at Coronary Angioplasty to Angiographic Restenosis Circulation, November 1, 1995; 92(9): 2473 - 2479. [Abstract] [Full Text]

				P. W. Serruys, P. de Jaegere, F. Kiemeneij, C. Macaya, W. Rutsch, G. Heyndrickx, H. Emanuelsson, J. Marco, V. Legrand, P. Materne, et al. A Comparison of Balloon-Expandable-Stent Implantation with Balloon Angioplasty in Patients with Coronary Artery Disease N. Engl. J. Med., August 25, 1994; 331(8): 489 - 495. [Abstract] [Full Text]